CRW Craneware Plc

TIDMCRW

RNS Number : 3859S

Craneware plc

23 September 2014

Craneware plc

("Craneware" or the "Company")

Grant of Options

23 September 2014 - The Board of Craneware plc (AIM: CRW.L), the market leader in automated revenue integrity solutions of the US healthcare market, announces that on 22 September 2014, the Remuneration Committee approved the granting of share options to certain Directors to subscribe for ordinary shares of 1p each in the Company as follows:

 
                                     No. of       Percentage 
                                    options        of issued 
 Director                           granted    share capital 
 
 Keith Neilson (Chief Executive 
  Officer)                           39,090             0.15 
 Craig Preston (Chief Financial 
  Officer)                           36,808             0.14 
 

The above options have been granted at an exercise price of 522.5p per share (being the closing market price on 22 September 2014). These options will be subject to performance criteria, such that they vest in three equal tranches over three years. One third of the share options will vest on or after 30 June 2015, one third on or after 30 June 2016 and the final third on or after 30 June 2017. The share options will not become exercisable until three years from the date of the grant.

For further information, please contact:

 
 Craneware plc    Peel Hunt         Newgate Threadneedle 
 +44 (0)131 550   +44 (0)20 7418 
  3100             8900             +44 (0)20 7653 9850 
 Keith Neilson,   Dan Webster       Caroline Forde 
  CEO 
 Craig Preston,   Richard Kauffer   Tim Thompson 
  CFO                                Heather Armstrong 
                                     Edward Treadwell 
 

About Craneware

Founded in 1999, Craneware has its headquarters in Edinburgh, Scotland with offices in Atlanta, Arizona, Massachusetts and Tennessee employing over 200 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance for healthcare organisations. Craneware's market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge, code and retain earned revenue for patient care services and supplies. This optimises reimbursement, increases operational efficiency and minimises compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSEAFNDAFPLEFF

Grafico Azioni Craneware (LSE:CRW)
Storico
Da Giu 2024 a Lug 2024

Grafico Azioni Craneware (LSE:CRW)
Storico
Da Lug 2023 a Lug 2024